drugset / Trial / NCT01853696

Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty

NCT01853696

Phase 4 Completed 167 enrolled Cornea Research Foundation of America
RandomizedParallel-groupSingle-blindPrevention

Summary

Graft rejection has traditionally been one of the leading causes of cornea transplant failure. To help prevent rejection, corticosteroid eye drops are used for an extended period after transplant surgery. The purpose of this study is to compare the efficacy and side effects of different corticosteroid dosing regimens after endothelial keratoplasty (cornea transplant) surgery.

Timeline

Start
2013-03
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Loteprednol Etabonate Other / unclassified 0.5 % Topical
Comparator Prednisolone Other / unclassified 1 % Topical